Article

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of Notch signaling

2020-10-21

Abstract excerpt

<h4>Background: </h4> Glioblastoma (GBM) is a lethal type of primary brain tumor with a median survival less than 15 months. Despite the recent improvements of comprehensive strategies, the outcomes for GBM patients remain dismal. Accumulating evidence indicates that rapid acquired chemoresistance is the major cause of GBM recurrence thus leads to worse clinical outcomes. Therefore, developing novel biomarkers and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4c91b730-1c8c-582d-81ea-ee2d1f4d6880
DOI: 10.21203/rs.3.rs-34246/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of Notch signalingDOI 10.21203/rs.3.rs-34246/v2Read

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signalingSemantic proximity Read

Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiformeSemantic proximity Read

Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastomaSemantic proximity Read

NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathwaySemantic proximity Read

Survival kinase genes present prognostic significance in glioblastomaSemantic proximity Read

PDZ-Binding Kinase-Dependent Transcriptional Regulation of CCNB2 Promotes Tumorigenesis and Radio-Resistance in GlioblastomaSemantic proximity Read

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-RadiotherapySemantic proximity Read

Spatiotemporal Dynamics of Intra-tumoral Dependence on NEK2-EZH2 Signaling in Glioblastoma Cancer ProgressionSemantic proximity Read

Comprehensive Analysis Reveals Promising Immune Target and Prognostic Value of PLK3 in GliomaSemantic proximity Read

Integrated Analysis Identifies MEOX2 as a Malignant Driver and Prognostic Biomarker in Brain GliomaSemantic proximity Read

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoSemantic proximity Read

RPL22L1, a Novel Candidate Oncogene Promotes Temozolomide Resistance by Activating STAT3 in GlioblastomaSemantic proximity Read